Mills-Peninsula Physician Receives International Achievement Award from American Diabetes Association
BURLINGAME, Calif. – Congratulations to David Klonoff, M.D., FACP, FRCP (Edin), Fellow AIMBE, medical director of the Diabetes Research Institute at Mills-Peninsula Medical Center, on being the 2019 recipient of the Outstanding Physician Clinician in Diabetes Award from the American Diabetes Association. This is the highest international award for a diabetes clinician and Dr. Klonoff is the first diabetes physician from Northern California to ever receive this award.
“Being a physician at Mills-Peninsula Medical Center (MPMC) has allowed me to meet many amazing physicians, nurses and educators here, and to work on projects that can benefit patients from San Mateo County, the United States and the entire world,” Dr. Klonoff said. “Development of cutting-edge treatments for diabetes, such as the artificial pancreas, new insulins, software for dosing diabetes medications, cybersecurity standards for wearable diabetes devices and new methods for measuring glucose and Hemoglobin A1c, are what we do at MPMC. I am very happy to be part of the great MPMC staff and to be recognized for my work as a diabetes clinician at MPMC.”
Dr. Klonoff has been a member of the medical staff at Mills-Peninsula Medical Center, part of Sutter Health, since 1981.
Dr. Klonoff, along with the seven additional recipients of the American Diabetes Association (ADA) 2019 National Scientific and Health Care Achievement Awards, will be honored in a special ceremony during the ADA’s 79th Scientific Sessions. More than 11,000 leading physicians, scientists and healthcare professionals from around the world are expected to convene at the Scientific Sessions, making it the world’s largest scientific meeting focused on diabetes research, prevention and care.
“This year’s National Scientific and Health Care Achievement Award recipients are distinguished global leaders in research, clinical care and academic medicine. Collectively, their incredible contributions and research discoveries have informed on important management strategies that helped us decrease the incidence of many serious complications of diabetes, address co-morbidities and improve quality of life for the millions of people living with diabetes,” said William T. Cefalu, M.D., Chief Scientific, Medical and Mission Officer of the ADA.
An endocrinologist specializing in the development and use of diabetes technology, Dr. Klonoff is the author of more than 300 publications and has been a principal investigator on more than 110 clinical trials, including the first randomized controlled multicenter trial of an outpatient artificial pancreas product. He chaired the scientific advisory board for developing the first FDA-approved insulin patch pump and participated in development of the first FDA-approved dedicated diabetes telemedicine system, the first FDA-approved inhaled insulin, and the first three FDA-approved incretin drugs for diabetes.
Dr. Klonoff has served as a civilian medical officer for the U.S. Army’s Telemedicine & Advanced Technology Research Center (TATRC) for biosensors and physiologic monitoring, and chaired the CDC’s initiative, “Sticking with Safety,” for safe blood glucose monitoring to avoid transmitting blood-borne viruses. He also led technical and clinical guideline panels about continuous glucose monitoring for CLSI and the Endocrine Society.
In 2010, Dr. Klonoff received the FDA Director’s Special Citation Award, and in 2012, he was elected as a Fellow of the American Institute of Medical and Biological Engineering. That same year, he also received the 2012 Gold Medal Oration and Distinguished Scientist Award from the Dr. Mohan’s Diabetes Specialties Centre and Madras Diabetes Research Foundation of Chennai, India, which is the world’s largest diabetes clinic. In 2000 Dr. Klonoff founded Mills-Peninsula’s Dorothy L. and James E. Frank Diabetes Research Institute to facilitate development of new devices and drugs for people with diabetes.
Dr. Klonoff is the founding editor-in-chief of the Journal of Diabetes Science and Technology, and founder of the Diabetes Technology Meeting, the Digital Diabetes Congress, and the Hospital Diabetes Meeting. As diabetes technology has become ever more connected, Dr. Klonoff has also become involved in advancing security standards for internet-connected medical devices. He is a member of the Healthcare Sector Coordinating Council Joint Cyber Working Group for Medical Devices/Healthcare, and chaired the groups developing the world’s first consensus medical device cybersecurity standards. He is also a clinical professor of medicine at the University of California, San Francisco (UCSF). Dr. Klonoff is a graduate of UC Berkeley, where he was elected to Phi Beta Kappa in his junior year, and UCSF Medical School, where he was elected to Alpha Omega Alpha in his junior year. His postgraduate training included two years at UCLA Hospital and three years at UCSF Hospitals.